• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

组蛋白去乙酰化酶 8(HDAC8)选择性抑制作用的特征分析揭示了特定的活性位点结构和功能决定因素。

Characterization of Histone Deacetylase 8 (HDAC8) Selective Inhibition Reveals Specific Active Site Structural and Functional Determinants.

机构信息

Institut de Génétique et Biologie Moléculaire et Cellulaire (IGBMC), Département de Biologie Structurale Intégrative , Université de Strasbourg, Centre National de la Recherche Scientifique (CNRS UMR7104), Institut National de la Santé et de la Recherche Médicale (INSERM U1258) , 1 rue Laurent Fries , 67404 Illkirch Cedex , France.

Institute of Pharmacy , Martin-Luther-Universität Halle-Wittenberg , Wolfgang-Langenbeck-Straße 4 , 06120 Halle/Saale , Germany.

出版信息

J Med Chem. 2018 Nov 21;61(22):10000-10016. doi: 10.1021/acs.jmedchem.8b01087. Epub 2018 Nov 8.

DOI:10.1021/acs.jmedchem.8b01087
PMID:30347148
Abstract

Metal-dependent histone deacetylases (HDACs) are key epigenetic regulators that represent promising therapeutic targets for the treatment of numerous human diseases. Yet the currently FDA-approved HDAC inhibitors nonspecifically target at least several of the 11 structurally similar but functionally different HDAC isozymes, which hampers their broad usage in clinical settings. Selective inhibitors targeting single HDAC isozymes are being developed, but precise understanding in molecular terms of their selectivity remains sparse. Here, we show that HDAC8-selective inhibitors adopt a L-shaped conformation required for their binding to a HDAC8-specific pocket formed by HDAC8 catalytic tyrosine and HDAC8 L1 and L6 loops. In other HDAC isozymes, a L1-L6 lock sterically prevents L-shaped inhibitor binding. Shielding of the HDAC8-specific pocket by protein engineering decreases potency of HDAC8-selective inhibitors and affects catalytic activity. Collectively, our results unravel key HDAC8 active site structural and functional determinants important for the design of next-generation chemical probes and epigenetic drugs.

摘要

金属依赖性组蛋白去乙酰化酶(HDACs)是关键的表观遗传调节剂,它们是治疗许多人类疾病的有前途的治疗靶点。然而,目前 FDA 批准的 HDAC 抑制剂不能特异性地靶向至少 11 种结构相似但功能不同的 HDAC 同工酶中的几种,这限制了它们在临床环境中的广泛应用。目前正在开发针对单个 HDAC 同工酶的选择性抑制剂,但对其选择性的分子术语的精确理解仍然很少。在这里,我们表明 HDAC8 选择性抑制剂采用 L 形构象,这是与由 HDAC8 催化酪氨酸和 HDAC8 L1 和 L6 环形成的 HDAC8 特异性口袋结合所必需的。在其他 HDAC 同工酶中,L1-L6 锁会阻碍 L 形抑制剂的结合。通过蛋白质工程屏蔽 HDAC8 特异性口袋会降低 HDAC8 选择性抑制剂的效力并影响催化活性。总的来说,我们的结果揭示了关键的 HDAC8 活性位点结构和功能决定因素,这些因素对于设计下一代化学探针和表观遗传药物很重要。

相似文献

1
Characterization of Histone Deacetylase 8 (HDAC8) Selective Inhibition Reveals Specific Active Site Structural and Functional Determinants.组蛋白去乙酰化酶 8(HDAC8)选择性抑制作用的特征分析揭示了特定的活性位点结构和功能决定因素。
J Med Chem. 2018 Nov 21;61(22):10000-10016. doi: 10.1021/acs.jmedchem.8b01087. Epub 2018 Nov 8.
2
Docking of hydroxamic acids into HDAC1 and HDAC8: a rationalization of activity trends and selectivities.将羟肟酸对接进入 HDAC1 和 HDAC8:对活性趋势和选择性的合理化解释。
J Chem Inf Model. 2009 Dec;49(12):2774-85. doi: 10.1021/ci900288e.
3
Thermodynamics of binding of structurally similar ligands to histone deacetylase 8 sheds light on challenges in the rational design of potent and isozyme-selective inhibitors of the enzyme.结构相似配体与组蛋白去乙酰化酶8结合的热力学为该酶高效且具有同工酶选择性抑制剂的合理设计面临的挑战提供了线索。
Biochemistry. 2014 Dec 9;53(48):7445-58. doi: 10.1021/bi500711x. Epub 2014 Nov 26.
4
Crystal structure of a eukaryotic zinc-dependent histone deacetylase, human HDAC8, complexed with a hydroxamic acid inhibitor.一种真核生物锌依赖性组蛋白脱乙酰酶——人类HDAC8与一种异羟肟酸抑制剂复合物的晶体结构。
Proc Natl Acad Sci U S A. 2004 Oct 19;101(42):15064-9. doi: 10.1073/pnas.0404603101. Epub 2004 Oct 11.
5
Structure of 'linkerless' hydroxamic acid inhibitor-HDAC8 complex confirms the formation of an isoform-specific subpocket.“无连接子”异羟肟酸抑制剂 - HDAC8复合物的结构证实了一种亚型特异性亚口袋的形成。
J Struct Biol. 2016 Sep;195(3):373-378. doi: 10.1016/j.jsb.2016.06.023. Epub 2016 Jun 29.
6
A distal regulatory region of a class I human histone deacetylase.I 类人组蛋白去乙酰化酶的远端调控区。
Nat Commun. 2020 Jul 31;11(1):3841. doi: 10.1038/s41467-020-17610-w.
7
The structural requirements of histone deacetylase inhibitors: C4-modified SAHA analogs display dual HDAC6/HDAC8 selectivity.组蛋白去乙酰化酶抑制剂的结构要求:C4修饰的SAHA类似物具有HDAC6/HDAC8双重选择性。
Eur J Med Chem. 2018 Jan 1;143:1790-1806. doi: 10.1016/j.ejmech.2017.10.076. Epub 2017 Oct 31.
8
Design, synthesis, and biological activity of NCC149 derivatives as histone deacetylase 8-selective inhibitors.NCC149衍生物作为组蛋白去乙酰化酶8选择性抑制剂的设计、合成及生物活性
ChemMedChem. 2014 Mar;9(3):657-64. doi: 10.1002/cmdc.201300414. Epub 2014 Jan 8.
9
Exploring the potential binding sites of some known HDAC inhibitors on some HDAC8 conformers by docking studies.通过对接研究探索一些已知的组蛋白去乙酰化酶(HDAC)抑制剂在某些HDAC8构象体上的潜在结合位点。
Appl Biochem Biotechnol. 2014 Aug;173(7):1907-26. doi: 10.1007/s12010-014-0976-1. Epub 2014 Jun 3.
10
Characterization of Conformationally Constrained Benzanilide Scaffolds for Potent and Selective HDAC8 Targeting.构象受限苯甲酰胺支架的特性研究及其作为高效和选择性 HDAC8 靶标的应用。
J Med Chem. 2020 Aug 13;63(15):8634-8648. doi: 10.1021/acs.jmedchem.0c01025. Epub 2020 Jul 31.

引用本文的文献

1
CryoEM structure of Rv2531c reveals cofactor-induced tetramer-dimer transition in a tuberculin amino acid decarboxylase.Rv2531c的冷冻电镜结构揭示了结核菌素氨基酸脱羧酶中辅因子诱导的四聚体-二聚体转变。
J Biol Chem. 2025 Jun 19;301(8):110394. doi: 10.1016/j.jbc.2025.110394.
2
A propidium iodide-based screen of the "Bug Box" against reveals potent inhibitors.一项基于碘化丙啶的针对“昆虫盒”的筛选发现了强效抑制剂。
Antimicrob Agents Chemother. 2025 Jul 2;69(7):e0003525. doi: 10.1128/aac.00035-25. Epub 2025 Jun 9.
3
Binding mechanism and distant regulation of histone deacetylase 8 by PCI-34051.
PCI-34051对组蛋白去乙酰化酶8的结合机制及远距离调控
Commun Biol. 2025 Feb 12;8(1):221. doi: 10.1038/s42003-025-07649-0.
4
Enhancing HDAC Inhibitor Screening: Addressing Zinc Parameterization and Ligand Protonation in Docking Studies.增强组蛋白去乙酰化酶抑制剂筛选:解决对接研究中的锌参数化和配体质子化问题。
Int J Mol Sci. 2025 Jan 20;26(2):850. doi: 10.3390/ijms26020850.
5
Replacement of the hydroxamic acid group in the selective HDAC8 inhibitor PCI-34051.取代选择性 HDAC8 抑制剂 PCI-34051 中的羟肟酸基团。
Bioorg Med Chem Lett. 2024 Aug 1;108:129810. doi: 10.1016/j.bmcl.2024.129810. Epub 2024 May 22.
6
Key structural requirements of benzamide derivatives for histone deacetylase inhibition: design, synthesis and biological evaluation.苯甲酰胺衍生物的关键结构要求对组蛋白去乙酰化酶的抑制作用:设计、合成与生物评价。
Future Med Chem. 2024;16(9):859-872. doi: 10.4155/fmc-2023-0122. Epub 2024 Apr 16.
7
Emerging therapeutic strategies in cancer therapy by HDAC inhibition as the chemotherapeutic potent and epigenetic regulator.通过组蛋白去乙酰化酶抑制作用作为化疗增敏剂和表观遗传调节剂在癌症治疗中新兴的治疗策略。
Med Oncol. 2024 Mar 5;41(4):84. doi: 10.1007/s12032-024-02303-x.
8
Effects of structurally distinct human HDAC6 and HDAC6/HDAC8 inhibitors against S. mansoni larval and adult worm stages.结构不同的人类HDAC6和HDAC6/HDAC8抑制剂对曼氏血吸虫幼虫和成虫阶段的影响。
PLoS Negl Trop Dis. 2024 Feb 28;18(2):e0011992. doi: 10.1371/journal.pntd.0011992. eCollection 2024 Feb.
9
Comparative Structure-Based Virtual Screening Utilizing Optimized AlphaFold Model Identifies Selective HDAC11 Inhibitor.利用优化的AlphaFold模型进行基于结构的比较虚拟筛选,鉴定出选择性HDAC11抑制剂。
Int J Mol Sci. 2024 Jan 22;25(2):1358. doi: 10.3390/ijms25021358.
10
Development of First-in-Class Dual Sirt2/HDAC6 Inhibitors as Molecular Tools for Dual Inhibition of Tubulin Deacetylation.开发首创的 Sirt2/HDAC6 双重抑制剂作为双重抑制微管去乙酰化的分子工具。
J Med Chem. 2023 Nov 9;66(21):14787-14814. doi: 10.1021/acs.jmedchem.3c01385. Epub 2023 Oct 30.